Topic: Pharmaceutical Pricing

A 2019 clip of Kamala Harris discussing the seizure of drug patents is linked to the Biden administration's 2023 "March-in rights" policy. This policy allows the government to seize patents for medicines developed with federal funding if prices are deemed too high. It is noted that the intelligence community has historically suppressed patents for national security reasons without public challenge.

A federal court in Washington blocked a Department of Health and Human Services mandate that would have required pharmaceutical companies to disclose drug prices in television advertisements. The court ruled that Congress had not granted HHS the specific power to enforce such a rule. Despite high list prices for medications like Lexapro, it is noted that many drug companies offer assistance programs that provide free or discounted medication to those who cannot afford it.

HHS Secretary Alex Azar announced a new rule requiring pharmaceutical companies to disclose the list price of drugs costing over $35 in television advertisements. The industry trade group, PhRMA, responded by proposing a voluntary web portal instead of on-air disclosure. The regulation aims to provide transparency, though critics argue it may confuse consumers who pay lower out-of-pocket costs through insurance.

Mylan CEO Heather Bresch faced intense questioning from a House Oversight Committee regarding the 400% price increase of life-saving EpiPens. Representative Scott DesJarlais and other lawmakers excoriated Bresch for profiting from a monopoly while the company's wholesale acquisition cost reached $608. Bresch defended the company by citing the introduction of a $300 generic version and programs to provide free devices to schools.

Claims are discussed regarding the renaming of polio symptoms to Guillain-Barre syndrome in cases where vaccines fail to provide immunity. The discussion also covers the high cost of the HPV vaccine, which can reach $800 for a two-shot series. The hosts describe a "sales cycle" where doctors use inconclusive pap smear results to pressure women into purchasing expensive and potentially unnecessary vaccinations.